The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Azelby Robert since 2016.
This trader's CIK number is 1656998.
At the time of last reporting, Azelby Robert was the Director of Adc Therapeutics Sa. (stock ticker symbol ADCT).
Also see all insider trading activities at Adc Therapeutics Sa.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ADCT | 0 | $0 | 6,995 | $20,215 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | JUNO | 0 | $0 | 143,491 | $11,867,768 | 139,334 | $6,274,360 |
| 2017 | JUNO | 0 | $0 | 34,201 | $1,539,666 | 6,666 | $168,583 |
| 2016 | JUNO | 0 | $0 | 12,921 | $311,848 | 0 | $0 |
2. Juno Therapeutics, Inc. (JUNO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-06-17 | ADCT | Sale | 6,995 | 2.89 | 20,215 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-02-12 | JUNO | Sale | 4,157 | 85.55 | 355,631 |
| 2018-02-08 | JUNO | Option Ex | 3,497 | 23.02 | 80,518 |
| 2018-02-08 | JUNO | Sale | 3,497 | 85.77 | 299,937 |
| 2018-02-01 | JUNO | Sale | 4,167 | 85.78 | 357,445 |
| 2018-02-01 | JUNO | Option Ex | 4,167 | 51.76 | 215,683 |
| 2018-01-22 | JUNO | Option Ex | 102,539 | 51.76 | 5,307,418 |
| 2018-01-22 | JUNO | Sale | 102,539 | 86.25 | 8,843,988 |
| 2018-01-17 | JUNO | Sale | 29,131 | 69.03 | 2,010,767 |
| 2018-01-17 | JUNO | Option Ex | 29,131 | 23.02 | 670,741 |
| 2017-12-18 | JUNO | Sale | 1,816 | 44.96 | 81,647 |
| 2017-11-02 | JUNO | Option Ex | 6,666 | 25.29 | 168,583 |
| 2017-11-02 | JUNO | Sale | 6,666 | 54.95 | 366,296 |
| 2017-09-13 | JUNO | Sale | 12,850 | 44.95 | 577,607 |
| 2017-08-29 | JUNO | Sale | 12,869 | 39.95 | 514,116 |
| 2016-11-10 | JUNO | Sale | 12,921 | 24.14 | 311,848 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Azelby Robert (Director of Adc Therapeutics Sa at the time of this reporting) see the Securities and Exchange Commission (SEC) website.